Acadia Healthcare Company (NDAQ:ACHC) Downgrade of Rating
Equity research analysts at Robert W. Baird’s equity division lowered Acadia Healthcare Company (NDAQ:ACHC)’s stock from “Outperform” to “Neutral” on Wednesday morning. The analysts at Robert W. Baird have a target price per share of $38.00 on ACHC or 21.37 % more upside.
According to data compiled by Thomson Reuters, Acadia Healthcare Company (NDAQ:ACHC)’s stock is covered by 16 equity analysts across the Street, with 0 analysts giving it a Sell rating, 16 a Buy rating, while 1 consider it a Hold. The 12-month consensus target price for the stock is $79.19, which reflects an upside potential of 142.32% over the current price.
Philadelphia Financial Management Of San Francisco Llc had the largest stake with ownership of 343,735 shares as of Q2 2015 for 3.76% of the stock exposure. Pennant Capital Management Llc is another notably bullish investment professional who is owning 2.01M shares of Acadia Healthcare Company or 3.49% of their stock exposure. In addition, Bain Capital Investors Llc have 3.08% of their stock exposure invested in the company for 3.45M shares. The Maryland-based fund Rock Springs Capital Management Lp disclosed it had acquired a stake worth about 2.87% of the investment professional’s stock portfolio in Acadia Healthcare Company. The Quebec – Canada-based fund Sectoral Asset Management Inc is also positive about the stock, possessing 924,678 shares or 2.81% of their stock exposure.
Acadia Healthcare Company (NDAQ:ACHC) Profile
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S.
Acadia Healthcare Company (NDAQ:ACHC) traded down -25.93% on 25 October, hitting $32.68. A total of 19.84M shares of the company’s stock traded hands. This is up from average of 923,908 shares. Acadia Healthcare Company has a 52 week low of $30.91 and a 52 week high of $54.34. The company has a market cap of $2.87B and a P/E ratio of 421.95.
Get the latest Acadia Healthcare Company (NDAQ:ACHC) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Robert W. Baird Decreases Acadia Healthcare Company (NDAQ:ACHC) Rating to “Neutral” from “Outperform” Having $38.00 TP appeared first on Octafinance.